Suppression of Sympathetic Nervous System During Fasting
Authors:
Open Access
- 1 November 1997
- journal article
- review article
- Published by Wiley in Obesity Research
- Vol. 5 (6) , 646-649
Abstract
Two days of fasting in rats significantly reduces the turnover of norepinephrine in the heart. In contrast to the effects of ganglionic blockade in fed controls, similar blockade in fasted animals is without significant effect on [3H]‐norepinephrine retention or endogenous norepinephrine in the heart. These data are consistent with suppression of centrally mediated sympathetic activity in the fasted state. The decrease in norepinephrine turnover during fasting is completely reversed by 1 day of refeeding.Keywords
This publication has 12 references indexed in Scilit:
- Dissociation of the Renin–Aldosterone System and Refractoriness to the Sodium-Retaining Action of Mineralocorticoid During Starvation in ManThe Journal of Clinical Endocrinology & Metabolism, 1974
- Adrenergic Modulation of Basal Insulin Secretion in ManDiabetes, 1973
- Noradrenaline concentration and turnover in different regions of the gastrointestinal tract of the rat: an approach to the evaluation of sympathetic activity in the gutGut, 1972
- Effects of Catecholamines on Metabolism1972
- Increased retention of norepinephrine-3H in vas deferens during nerve stimulationAmerican Journal of Physiology-Legacy Content, 1970
- Urinary Excretion of Epinephrine and Norepinephrine During Fasting in Late Pregnancy in the Rat1Endocrinology, 1969
- Influence of Pituitary, Thyroid, and Adrenal Hormones on Norepinephrine Turnover and Metabolismin the Rat HeartCirculation Research, 1968
- Some Data on the Metabolic Function of the Adrenergic Nervous System in the Obese and During StarvationThe Journal of Clinical Endocrinology & Metabolism, 1968
- Letters to the Editor: Urinary Excretion of Catecholamines in Fasting Obese SubjectsThe Journal of Clinical Endocrinology & Metabolism, 1967
- EFFECT OF DECENTRALIZATION AND GANGLIONIC BLOCKING AGENTS ON THE SPONTANEOUS RELEASE OF H3-NOREPINEPHRINEThe Journal of Pharmacology and Experimental Therapeutics, 1962